Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease

NCT01522716 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT01522716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01522716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease
Lead sponsor
Karolinska Institutet
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2011
Completion date
March 31, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease